We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

PLSG Invests $100,000 in Proteopure to Speed up Protein Research

PLSG Invests $100,000 in Proteopure to Speed up Protein Research

PLSG Invests $100,000 in Proteopure to Speed up Protein Research

PLSG Invests $100,000 in Proteopure to Speed up Protein Research

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "PLSG Invests $100,000 in Proteopure to Speed up Protein Research "

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Dr. Doros Platika, M.D., President and Chief Executive Officer of The Pittsburgh Life Sciences Greenhouse (PLSG) has announced PLSG has invested $100,000 in Proteopure, a spinout of Carnegie Mellon University and founded by LaunchCyte.

Proteopure is developing technology to improve the methodology for isolating and reproducing proteins in medical research. The PLSG investment is provided under its Technology Development Fund (TDF) program.

"Proteopure is working to relieve bottlenecks in biomedical progress by giving researchers novel protein purification products," said Rich Ekstrom, Chief Executive Officer of Proteopure.

"Our technology is conceptually very simple, but it is different than all of the competitive products and eliminates a major problem for researchers. There has been an unmet need for a universal sample preparation methodology."

"We believe Proteopure addresses this by providing the first universal method for isolating proteins. This will decrease the time spent on optimizing protein isolation protocols."

The technology involves a molecule that reversibly binds all proteins. At the heart of the Proteopure 2DE sample preparation Kit is a "spin column," an apparatus that can be used in a standard laboratory centrifuge.

The spin column is packed with a resin that binds proteins via interaction with the proprietary protein-capture molecule.

Contaminants are washed away while proteins are immobilized on the resin. Initial commercial availability of the product is expected in 2006.